Literature DB >> 2769491

Transfer of anti-glomerular basement membrane antibody-induced glomerulonephritis in inbred rats with isologous antibodies from the urine of nephritic rats.

Y Sado1, I Naito, T Okigaki.   

Abstract

Anti-glomerular basement membrane antibody-induced glomerulonephritis (anti-GBM nephritis) was transferred from nephritic rats to normal recipient rats with isologous antibodies obtained from the urine of the nephritic rats. The original actively-immunized anti-GBM nephritis was induced in inbred WKY/NCrj rats by injecting the nephritogenic antigen from bovine renal basement membranes. Excreted urinary antibodies were collected, purified, and then injected into recipient rats of the same strain. Haematuria and proteinuria appeared on day 2 and day 3, respectively; both became heavier and reached a plateau by day 5. Endocapillary hypercellularity of mononuclear cells in glomeruli was the first histological change, which was observed from day 2, and later extracapillary changes such as fibrin deposition, capsular adhesion, and crescent formation were observed. These histological changes were the same as those seen in the actively-immunized nephritis. The results demonstrate that anti-GBM nephritis is clearly induced by autoantibodies. This new passively-immunized model of anti-GBM nephritis makes it possible and easier to analyse further the mechanism of anti-GBM nephritis because only isologous antibodies are used. This study also indicates that the urine of the nephritic rat is a good source of autoantibodies.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2769491     DOI: 10.1002/path.1711580410

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  11 in total

1.  What sensitized cells just might be doing in glomerulonephritis.

Authors:  W Kline Bolton
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

2.  Cyclosporin A in the prevention and treatment of experimental autoimmune glomerulonephritis in the brown Norway rat.

Authors:  J Reynolds; S J Cashman; D J Evans; C D Pusey
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

3.  Identification of a nephritogenic immunodominant B and T cell epitope in experimental autoimmune glomerulonephritis.

Authors:  J Reynolds; J Haxby; J K Juggapah; D J Evans; C D Pusey
Journal:  Clin Exp Immunol       Date:  2008-11-25       Impact factor: 4.330

4.  Nephritogenicity and alpha-chain composition of NC1 fractions of type IV collagen from bovine renal basement membrane.

Authors:  S Rauf; M Kagawa; Y Kishiro; S Inoue; I Naito; T Oohashi; M Sugimoto; Y Ninomiya; Y Sado
Journal:  Virchows Arch       Date:  1996-07       Impact factor: 4.064

Review 5.  Strain differences and the genetic basis of experimental autoimmune anti-glomerular basement membrane glomerulonephritis.

Authors:  John Reynolds
Journal:  Int J Exp Pathol       Date:  2011-02-23       Impact factor: 1.925

6.  Antibodies against linear epitopes on the Goodpasture autoantigen and kidney injury.

Authors:  Xiao-yu Jia; Zhao Cui; Rui Yang; Shui-yi Hu; Ming-hui Zhao
Journal:  Clin J Am Soc Nephrol       Date:  2012-03-29       Impact factor: 8.237

7.  Antibodies against linear epitopes on Goodpasture autoantigen in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Xiao-Yu Jia; Jun-Tao Yu; Shui-Yi Hu; Jian-Nan Li; Miao Wang; Chen Wang; Min Chen; Zhao Cui; Ming-Hui Zhao
Journal:  Clin Rheumatol       Date:  2017-05-26       Impact factor: 2.980

8.  IL-23, not IL-12, directs autoimmunity to the Goodpasture antigen.

Authors:  Joshua D Ooi; Richard K S Phoon; Stephen R Holdsworth; A Richard Kitching
Journal:  J Am Soc Nephrol       Date:  2009-04-08       Impact factor: 10.121

9.  Mucosal tolerance induced by an immunodominant peptide from rat alpha3(IV)NC1 in established experimental autoimmune glomerulonephritis.

Authors:  John Reynolds; Danielle S Abbott; Julieta Karegli; David J Evans; Charles D Pusey
Journal:  Am J Pathol       Date:  2009-04-30       Impact factor: 4.307

10.  CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis.

Authors:  J Reynolds; F W Tam; A Chandraker; J Smith; A M Karkar; J Cross; R Peach; M H Sayegh; C D Pusey
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.